EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease

Giovanni Petralli, Antonio Salvati, Domenico Tricò, Gabriele Ricco iD, Piero Colombatto, Maurizia Rossana Brunetto, Anna Solini iD

Diabetes/Metabolism Research and Reviews · 2024

DOI: 10.1002/dmrr.3736 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2024. Verfasst von Giovanni Petralli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Insulin Resistance. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Pisa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Insulin resistance (IR) plays a pivotal role in the pathogenesis of Metabolic dysfunction‐Associated Fatty Liver Disease (MAFLD), which can progress to liver fibrosis. We examined the relationship of different IR scores with markers of MAFLD severity in obese individuals. Materials and Methods In this retrospective observational study, 346 non‐diabetic, overweight/obese individuals with newly diagnosed MAFLD (age 50.2 ± 13.3 years, 34% females, BMI 30.8 ± 4.4 kg/m 2 ) underwent liver stiffness (LS) and controlled attenuation parameter (CAP) measurements by Fibroscan® to assess liver fibrosis and steatosis. Biochemical data were collected to calculate surrogate markers of IR (Homoeostasis model assessment ‐ insulin resistance index [HOMA‐IR], triglyceride‐glucose index, triglyceride by HDL ratio), liver fibrosis (Nonalcoholic Fatty Liver Diseases fibrosis score, fibrosis‐4 score, Aspartate aminotransferase to platelet ratio index) and steatosis (fatty liver index, hepatic steatosis index).

Results

All three IR scores were associated with CAP, while only HOMA‐IR positively correlated with LS ( r = 0.275, p < 0.0001), independent of age and sex, BMI, transaminases, and fibrosis markers. Insulin‐resistant individuals (HOMA‐IR >2.5, n = 165) had higher liver enzymes, CAP and LS, with a 4‐fold increased risk of severe liver disease (LS >9.7 kPa, OR 4.42[1.95–10.01], p = 0.0002). Among HOMA‐IR components, fasting plasma insulin (FPI) was independently associated with LS ( r = 0.270, p < 0.0001). ROC AUC for HOMA‐IR and FPI to predict severe liver disease were virtually identical (0.748 and 0.758, respectively).

Conclusions

HOMA‐IR is independently associated with non‐invasive markers of MAFLD severity in overweight/obese individuals. This relationship is largely mediated by hyperinsulinemia, regardless of BMI. Measuring insulin levels in MAFLD individuals might be useful to identify those at risk of liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseInsulin ResistanceFemaleHumansAdultMiddle AgedMaleOverweightBody Mass IndexObesityLiver CirrhosisInsulinFibrosisTriglycerides

Stichwörter der Autor:innen

FibroscanHOMA-indexMAFLDobesity

Substanzen

InsulinTriglycerides

Autor:innen und Institutionen

  • Department of Surgical Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
  • Hepatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

ORCID-Profile: Gabriele Ricco, Anna Solini

Förderung

  • University of Pisa

Zitieren

APA

Petralli, G., Salvati, A., Tricò, D., Ricco, G., Colombatto, P., Brunetto, M. R., & Solini, A. (2024). Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3736

Vancouver

Petralli G, Salvati A, Tricò D, Ricco G, Colombatto P, Brunetto MR, et al. Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3736

BibTeX
@article{Petralli2024,
  author = {Petralli, Giovanni and Salvati, Antonio and Tricò, Domenico and Ricco, Gabriele and Colombatto, Piero and Brunetto, Maurizia Rossana and Solini, Anna},
  title = {Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  doi = {10.1002/dmrr.3736}
}
Kostenlos starten →